A groundbreaking clinical trial at the University of Chicago has potentially cured all 12 participants of Type 1 diabetes. The procedure involves transplanting cells on the pancreas – called islet cells – in combination with a new drug to prevent rejection. NBC News’ Anne Thompson has a closer look.
Author: NBC News
This post was originally published on NBC News.
Leave a Reply